Harris has reaped a windfall of campaign funds since Democrats backed her to replace President Joe Biden after he withdrew ...

Howard Lutnick, the head of investment bank Cantor Fitzgerald and financial-technology company BGC Group, is breaking into ...

Louise Chen, Cantor Fitzgerald senior analyst, joins ‘Squawk Box’ to discuss Novo Nordisk's CEO on Capitol Hill, when drug ...

Cantor Fitzgerald initiated coverage of Amgen with an Overweight rating and $405 price target. The firm views Amgen’s obesity ...

Fintel reports that on September 27, 2024, Cantor Fitzgerald initiated coverage of Amgen (NasdaqGS:AMGN) with a Overweight ...

Cantor Fitzgerald has recently initiated Innoviva Inc (INVA) stock to Overweight rating, as announced on June 18, 2024, according to Finviz. Earlier, on July 20, 2022, Goldman had initiated the stock ...

Cantor Fitzgerald CEO Howard Lutnick argues Trump's tariff and tax plan was "amazing" for the U.S. economy while Kamala ...

On Friday, Vera Therapeutics Inc (VERA) stock saw a decline, ending the day at $43.44 which represents a decrease of $-2.22 or -4.86% from the prior close of $45.66. The stock opened at $46.12 and ...

Cantor Fitzgerald analyst Pete Stavropoulos maintained a Buy rating on Vera Therapeutics (VERA – Research Report) yesterday and set a ...

In a report released on September 20, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Nano-X Imaging (NNOX – Research ...

Cantor Fitzgerald Managing Director Louise Chen noted that price of weight loss drugs from Novo Nordisk and Eli Lilly should ...

Cantor Fitzgerald Large Cap Focused Fund earns an Above Average Process Pillar rating. The most significant contributor to the rating is the parent firm's five-year risk-adjusted success ratio of ...